Drug Trial Radar · NCT04329728
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Last checked: Nov 19, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
144
Planned (sponsor's estimate)
Start
Nov 6, 2020
Primary completion
Nov 30, 2027
Study completion Dec 1, 2028
Sponsor
- Lead sponsor
- AVM Biotechnology IncIndustry
- Sponsor type
- Industry
- Collaborators
- Medpace, Inc.
- First posted
- Apr 1, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 95 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 administered as a single intravenous (IV) infusion to patients with lymphoid malignancies.
Conditions
- Lymphoid Malignancies
Interventions
AVM0703Drug
Intravenous infusion over \~1 hours
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1: incidence of Adverse eventsTime frame: Year One
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
City of Hope
Duarte, California · Recruiting
Los Angeles Cancer Network
Los Angeles, California · Recruiting
UCLA Medical Center of Hematology/Oncology
Los Angeles, California · Recruiting
Innovative Clinical Research Institute
Whittier, California · Recruiting
ASCLEPES Research Centers
Weeki Wachee, Florida · Recruiting
University of Illinois at Chicago Cancer Center
Chicago, Illinois · Recruiting
Norton Cancer Institute
Louisville, Kentucky · Recruiting
Oncology Hematology West P.C. dba Nebraska Cancer Specialists
Omaha, Nebraska · Recruiting
Gabrail Cancer Center Research,
Canton, Ohio · Recruiting
Baptist Clinical Research Institute
Memphis, Tennessee · Recruiting
University of Texas(UT) Southwestern-Children's Medical Center
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.